BioMed Alliance

About the BioMed Alliance

The Biomedical Alliance in Europe (BioMed Alliance) is a non-profit organisation representing more than 30 European research and medical societies uniting more than 400,000 researchers and healthcare professionals. Mission The BioMed Alliance is committed to promoting excellence and innovation in the European healthcare field with the goal of improving the health and well-being of all European citizens It promotes the interests of researchers and healthcare professionals organised in not-for-profit scientific medical associations and organisations, across all medical disciplines.


New BioMed Alliance Statement: Open Access Initiatives must not create inequality

Together with medical societies from the Open Access Transition Working Group of the BioMed Alliance we published a statement on 5 October highlighting a series of concerns around Plan S. The statement also expresses support for a European Research Council statement from 20 July stating the ERC’s concerns around this open access initiative and announcing their withdrawal from cOAlition S.

Our main concerns regarding Plan S are focussed on the consequences for: researchers (including inequality and rising costs), guaranteeing the quality of research (especially in health research) and hybrid journals (which play an essential role in informing health care professionals through medical society publications).

The full statement is available here.


In July 2019, the Biomedical Alliance in Europe issued a Statement urging Member States to support EU-level Health Technology Assessment (HTA). Health technologies are used for the diagnosis, treatment and management of diseases. Those health technologies are as fundamental to good healthcare as the clinical expertise of Medical Societies is to the evaluation of new technologies. The Biomedical Alliance welcomed the Commission  and European Parliament proposals  for a Regulation on HTA as contributing to create a robust and effective framework for collaborative EU-level HTA.

Read the letter here.


The BioMedAlliance has sent an open letter to the President of the European Commission, Ursula von der Leyen, regarding the importance of maintaining and fostering health research in Europe: Read the letter ‘Europe should fill the gap and exercise leadership in health research; it is time to coordinate health research efforts across Europe through the implementation of a European Health Research Council’ by clicking here.

Read the letter here.

See the flyer here.

 

Related Information

European Union Policies on RMDs

A list of European Union policies, declarations and document repository around the topic on Rheumatic Musculoskeletal Diseases (RMDs). Read more


EULAR and Europe

EU actions are important in promoting the economic and social inclusion of people with disabilities. Read more


EULAR RheumaMap
A Research Roadmap to transform the lives of  people with Rheumatic and Musculoskeletal Diseases. Read more


Areas of Interest
Employment, social affairs, disability, public health and research. Read more


Activities and events
With the aim to bring together policy makers, the RMD community and other key stakeholders to discuss on specific topics of issues affecting people with RMD (and other chronic conditions), EULAR organises a number of activities and events each year. Read more


EULAR Policy statements and reports

As part of its advocacy activities, EULAR produces and adopts a number of documents and declarations that are used to express EULAR’s position and/or demands on different policy issues. Read more

Links to other organisations

Partnerships that help to increase the knowledge of the organisations involved and the impact they can have on the political stage. Read more